Publications en collaboration avec des chercheurs de Hospital Infanta Cristina (12)

2020

  1. Evolution of the antimicrobial resistance rates in clinical isolates of Pseudomonas aeruginosa causing invasive infections in the south of Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 150-154

2017

  1. Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme

    PLoS ONE, Vol. 12, Núm. 3

  2. Response to bile salts in clinical strains of Acinetobacter baumannii lacking the adeABC efflux pump: Virulence associated with quorum sensing

    Frontiers in Cellular and Infection Microbiology, Vol. 7, Núm. MAY

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

  2. Sarcoidosis: an update on current pharmacotherapy options and future directions

    Expert Opinion on Pharmacotherapy, Vol. 17, Núm. 18, pp. 2431-2448

  3. Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients

    Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 2, pp. 142-152

2012

  1. Measurement of asthma control according to global initiative for asthma guidelines: a comparison with the asthma control questionnaire

    Respiratory Research, Vol. 13

  2. The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem?

    Clinical Microbiology and Infection, Vol. 18, Núm. 7

2011

  1. Impact of obesity in patients infected with 2009 influenza A(H1N1)

    Chest, Vol. 139, Núm. 2, pp. 382-386

2008

  1. Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens

    HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313

2006

  1. Encuesta de ética en las unidades de cuidados intensivos pediátricos españolas

    Anales de Pediatria, Vol. 64, Núm. 6, pp. 542-549

2003

  1. A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer

    Cancer Chemotherapy and Pharmacology, Vol. 52, Núm. 4, pp. 339-345